Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease
European Journal of Gastroenterology & Hepatology | Feb 16, 2018
European Journal of Gastroenterology & Hepatology | Feb 16, 2018